BioCatalystWatch
GERNWorkspace / GERN / OverviewCompany library
Price
Market cap
Next catalystDec 12, 2026RYTELO (imetelstat) plus ruxolitinib — IMproveMF · Data readoutCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

RYTELO (imetelstat)RYTELO (imetelstat) plus ruxolitinib — IMproveMF

Telomerase

PreINDP1P2P3FilingApproved
Upcoming / outlook

RYTELO (imetelstat)

Telomerase

Upcoming / outlook

RYTELO (imetelstat)

Telomerase

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

RYTELO (imetelstat)RYTELO (imetelstat) plus ruxolitinib — IMproveMF

Telomerase

PreINDP1P2P3FilingApproved
Upcoming / outlook

RYTELO (imetelstat)

Telomerase

PreINDP1P2P3FilingApproved
Upcoming / outlook

RYTELO (imetelstat)

Telomerase

Upcoming / outlook

Other pipelines

Approved / commercial

RYTELO (imetelstat)

Telomerase

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

History / paused

RYTELO (imetelstat)

Telomerase

PreINDP1P2P3FilingApproved
RYTELO (imetelstat)

Telomerase

PreINDP1P2P3FilingApproved
RYTELO (imetelstat)

Telomerase

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

GERN PR & News

PR & News

GERN SEC archive